Myriad Genetics partners with AWS to enhance Image Genius, speeding up document processing, and improving insurance workflows ...

It’s no secret that modern humans and Neanderthals interbred: most of the world’s population today has around 1 or 2 percent ...

SOPHiA GENETICS is tasked with developing its Solid Tumor application as a decentralised companion diagnostic.

How readily a cell divides and how well it survives are fundamental to life, shaping everything from organ size to the body's ability to withstand disease. That combination, known as cell fitness, isn ...

As climate change, shrinking water supplies and rising global food demand place increasing pressure on agriculture, ...

Genetics is the study of genes and how they influence characteristics and health. Through a variety of technological methods, environmental factors, and lifestyle choices, it is possible to alter some ...

Opus Genetics, Inc. (IRD) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to a loss of $0.12 per share a year ago. These figures ...

View SOPHiA GENETICS SA SOPH stock quote prices, financial information, real-time forecasts, and company news from CNN.

OPGx-BEST1 Cohort 1 Topline Data Expected in Second Week of September 2026 Enrollment Completed in LCA5 Registrational Trial ...

Second quarter 2026 revenue of $190.7 million decreased 11% year-over-year, reflecting a 1% decline in volume and a 9% decrease in average revenue per test year-over-year. The company is engaging ...

Topline six-month efficacy data expected by end of 2027 Phase 3 study follows FDA alignment on registrational trial design through Rare Disease Evidence Principles (RDEP) program Opus Genetics may sub ...

Health Secretary Robert F. Kennedy Jr. continues to falsely claim that vaccines cause autism despite overwhelming research to the contrary. Scientists say autism is primarily genetic, pointing to twin ...